[Danger of associated reserpine and electroshock; akathisia appearing during neuroleptic treatment].
D000959:Antihypertensive Agents; D014150:Antipsychotic Agents; D003295:Convulsive Therapy; D004565:Electroconvulsive Therapy / Q000150:complications*; D004597:Electroshock; D001523:Mental Disorders; D011595:Psychomotor Agitation; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D011618:Psychotic Disorders; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000009:adverse effects*
D000959:Antihypertensive Agents; D014150:Antipsychotic Agents; D046948:Secologanin Tryptamine Alkaloids; D012110:Reserpine
PSYCHOSES, TOXIC/etiology and pathogenesis; RAUWOLFIA ALKALOIDS/injurious effects; SHOCK THERAPY, ELECTRIC/complications
Danger de l'association réserpine-électro-choc; acathisie apparue au cours du traitement neuroleptique.